DMC Best Practices: What Biotechs and Sponsors Should Know  

1 minute read

Published: August 5th, 2025

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safety of an investigational product and at times the futility/efficacy. Successfully navigating DMC set-up, logistics, and independent data review can be complex, especially for biotech and smaller sponsors without in-house expertise. 

Speakers:
  • Lucy Clark, Statistics Manager
  • Lisa Gibbons, Senior Statistician
  • Matt George (Moderator), Senior Statistician
Learning Points :
  • Share best practices for establishing and running an effective Data Monitoring Committee
  • Explore the critical role of an Independent Data Analysis Centre (IDAC) in ensuring compliant, high-quality DMC operations.
  • Present real-world case studies showcasing successful DMC implementation in high-stakes clinical trials.
Complete the form below to access the recording and slides:

Related articles

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

November 20th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...

SDTM Workflow Transformation: Faster, Easier and More Reliable

SDTM Workflow Transformation: Faster, Easier and More Reliable

November 14th, 2025 1 minute read

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech ...

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

October 30th, 2025 1 minute read

The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ul...